New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
Advertisement
TMED
US Health Care
Active

T. Rowe Price Health Care ETF

This ETF provides exposure to Other US Health Care Equities

TMED performance and flow charts

Last update 10/23/2026 at 1:30 PM
Live
Closed
Last price
$34.08
-$0.41 (-1.20%) 10/23/2026

Performance

-5.0-4.0-3.0-2.0-1.00.0%Sep 22Sep 29Oct 6Oct 13Oct 20

Flows

0 M0.5 M1 M1.5 M
1 day price range
$34.00
$34.15
52 week price range
$27.65
$36.68
1W perf
+1.66%
YTD perf
+16.23%
YTD flows
+$15M
AuM
$34M
E/R
0.44%
TTM yield
0.47%
Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

Historic performance and flows

Data as of October 22, 2026
1M3MYTD1Y3Y5Y
Perf.-0.47%+2.02%+16.23%+21.78%
Flows+$2M+$10M+$15M+$16M--
Data as of October 22, 2026
Advertisement

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Characteristics

This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.

Management strategyActive
StrategyLong Only
ProviderT. Rowe Price
N° of holdings106
Dividend policyDistributing
Trailing 12m distribution yield
Join for free
Inception dateJune 11, 2025
ESGNo
TrackinsightTrackinsight

More data and info about TMED on Trackinsight

Exposure

Data as of August 31, 2026

Diversification

56.93%

Total weight of top 15 holdings out of 106

Top 15 Holdings

Eli Lilly & Co.
13.87%
UnitedHealth Group, Inc.
5.32%
Alnylam Pharmaceuticals, Inc.
5.2%
Thermo Fisher Scientific, Inc.
3.74%
Cencora, Inc.
3.65%
Insulet Corp.
3.23%
Gilead Sciences, Inc.
2.99%
Agilent Technologies, Inc.
2.85%
Elanco Animal Health, Inc.
2.63%
Dyne Therapeutics, Inc.
2.47%
Boston Scientific Corp.
2.25%
Stryker Corp.
2.21%
Danaher Corp.
2.2%
Waters Corp.
2.17%
West Pharmaceutical Services, Inc.
2.16%

Sectors

Healthcare
98.26%
Other
1.74%

Countries

USA
92.86%
Other
7.14%
Advertisement

Trading data

Last sale
10/23/2026 at 1:30 PM
$34.08
Previous close
$34.49
Consolidated volume
10/22/2026
Join for free
Average volume
30 days
Join for free
Average discount or premium
30 days
Join for free
Average Bid/Ask spread
30 days
Join for free

Volatility and drawdown

3M1Y3Y5Y
Volatility+19.33%+18.68%
Max drawdown
-10.10%-11.09%
Max drawdown duration
64d125dN/AN/A
Time to recover
N/A62dN/AN/A
Advertisement
Frequently asked questions about TMED

What type of ETF is TMED?

TMED is a Active ETF that provides exposure to Equity assets. It is managed by T. Rowe Price.

What does TMED invest in?

This ETF provides exposure to Other US Health Care Equities. It is part of the segment: US Health Care.

What is the expense ratio of TMED?

The total expense ratio (TER) of TMED is 0.44%, representing the annual fee charged by the fund manager.

When was TMED launched?

TMED was launched on June 11, 2025, marking its entry into the ETF market.

Who is the issuer of TMED?

TMED is issued by T. Rowe Price.

What is the AUM of TMED?

As of October 22, 2026, TMED manages $34.50 M, reflecting the total assets held in the fund.

How has TMED performed recently?

As of October 22, 2026, TMED delivered a return of -0.47% over the past month (1M performance), 2.02% over the past three months (3M), and 16.23% year-to-date (YTD).

What are the recent fund flows for TMED?

As of October 22, 2026, TMED has seen net flows of +$2M in the past month (1M flow) and +$15M year-to-date (YTD).

Does TMED pay dividends?

As of October 22, 2026, TMED has a trailing 12-month distribution yield of 0.47%.

How many holdings are in TMED

As of August 31, 2026, TMED holds 106 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.

How diversified is TMED?

As of August 31, 2026, TMED holds 106 securities, with 56.93% of its assets concentrated in its top 15 holdings.

What are the top holdings of TMED?

As of August 31, 2026, TMED holds a portfolio of 106 underlyings, with its largest positions including Eli Lilly & Co., UnitedHealth Group, Inc. and Alnylam Pharmaceuticals, Inc.. These top holdings play a significant role in shaping the fund’s performance and exposure.

What countries or regions does TMED invest in?

As of August 31, 2026, TMED has its largest geographic exposures in USA.

What sectors or themes does TMED focus on?

As of August 31, 2026, TMED is primarily exposed to Healthcare.

The ETF Institute® is now affiliated with ETF Central

The CETF certification is the only FINRA listed professional designation focused on ETFs.

ETF Institute
Advertisement
Advertisement
ETF U
Become a better investor with NYSE: The Home of ETFs
Visit the ETF U homepage
ETF Guides
Advertisement

Recent educational content

ETF Investing Trends - First Look

First Look ETF

First Look ETF: Income, International, and Cash Flow ETFs

In this season 6 episode of First Look ETF, Stephanie Stanton ‪@etfguide‬ examines the latest ETF marketplace trends with NYSE and guests.

ETF Guide
By ETF Guide · October 20, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs October 5, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · October 6, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs September 28, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · September 29, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs September 22, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · September 23, 2026

Browse all educational columns

New Report

ETFs’ Next Act: From Access to Selection

Global ETF Survey 2026